Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2025-01-16 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
诉讼进展公告
Legal Proceedings Report Classification · 100% confidence The document is a litigation progress announcement from Dongbei Pharmaceutical Group Co., Ltd. It details a recent court judgment related to a contract dispute, including the court's decision, compensation amounts, and legal fees. It also mentions the company's intention to apply for a retrial and the potential impact on profits. The document does not contain financial statements or detailed financial analysis but focuses on legal proceedings and their implications. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 1594 characters, which is consistent with a detailed announcement rather than a full financial report.
2025-01-16 Chinese
第九届董事会第三十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 35th meeting of the 9th Board of Directors of Dongbei Pharmaceutical Group Co., Ltd. It details the meeting attendance, the legality of the meeting procedures, and the approval of a donation proposal. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory filings beyond the board meeting resolution. The content focuses on board decisions and meeting outcomes, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. Therefore, the classification is MANG with high confidence.
2025-01-08 Chinese
关于向西藏日喀则市定日县地震灾区捐赠的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding a donation to an earthquake disaster area. It includes details about the donation amount, the board meeting approval, and the impact on the company. There is no financial report, no earnings data, no regulatory certification, or any mention of a report being published or attached. The content is a corporate announcement about a social responsibility action, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement related to corporate social responsibility and board approval, which is best classified under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2025-01-08 Chinese
关于公司财务总监辞职暨聘任财务总监的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's financial director and the appointment of a new financial director. It includes details about the outgoing and incoming financial directors, their shareholdings, qualifications, and compliance with relevant laws and regulations. There is no financial data, report, or presentation included. This type of document fits the category of Board/Management Information (MANG), as it concerns changes in senior management positions.
2024-12-23 Chinese
第九届董事会第三十四次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of a board meeting resolution by Northeast Pharmaceutical Group Co., Ltd. It details the convening of the 34th meeting of the 9th Board of Directors, the attendance, the legality of the meeting, and the approval of the appointment of a new Chief Financial Officer. It references another announcement for details on the CFO appointment. The document is short (629 characters) and focuses on board/management changes rather than financial results or reports. Therefore, it fits the category of Board/Management Information (MANG).
2024-12-23 Chinese
关于获得化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company (Northeast Pharmaceutical Group Co., Ltd.) regarding the approval of a chemical raw material drug listing application by the National Medical Products Administration. It details the approval notice, product information, and the impact on the company. The document is short (1177 characters) and serves as an official announcement of regulatory approval rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or detailed report data. It is not a report publication announcement of a financial report but a regulatory announcement about product approval. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-18 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.